Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancer

Chougule, AnilSharma, RashmiTrivedi, V.Thavamani, AbhishekNoronha, VanitaJoshi, AmitDesai, SaralChandrani, P.Sundaram, P.Utture, S.Jambhekar, N.Gupta, SanjeevAich, J.Prabhash, KumarDutt, Amit2019-02-122019-02-122014British Journal Of Cancer. -111 : 11 (2014), p. 2203-2204. -Br. J. Cancer. - 0007-09200007-0920http://hdl.handle.net/2437/263763Coexistence of KRAS mutation with mutant but not wild-type EGFR predicts response to tyrosine-kinase inhibitors in human lung cancerfolyóiratcikkopen access articlehttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM077095OrvostudományokElméleti orvostudományokhttp://www.nature.com/articles/bjc2014401http://dx.doi.org/10.1038/bjc.2014.4012020-09-11